health-issue
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
https://ift.tt/9jREJP0 Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent D…
Read more
health-issue
Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
https://ift.tt/CQreAx9 Japan first in the world to approve Dupixent ® for chronic spontaneous urticaria (CSU) from Sanofi - Aventis Groupe https:…
Read more
health-issue
Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS
https://ift.tt/OVXPp3M from Sanofi - Aventis Groupe https://ift.tt/7FdRqyh via IFTTT
Read more
health-issue
Media Update: New data presented at AAAAI highlight Sanofi’s scientific leadership across inflammatory diseases
https://ift.tt/hZ8fBmF New data presented at AAAAI highlight Sanofi’s scientific leadership across inflammatory diseases from Sanofi - Aventis Gro…
Read more
health-issue
Media Update: New data demonstrate clinical safety, benefit and durability of Nexviazyme® across a wide-range of Pompe disease patient groups
https://ift.tt/2hOuSPT New data demonstrate clinical safety, benefit and durability of Nexviazyme ® across a wide-range of Pompe disease patient gro…
Read more
health-issue
Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses
https://ift.tt/aqmnoeG from Sanofi - Aventis Groupe https://ift.tt/LQmnevN via IFTTT
Read more
health-issue
Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
https://ift.tt/ANKp8mk Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology P…
Read more